10 result for author: REMAb


RemAb’project has been selected as a CaixaImpulse Consolidate

The Project "RA01: A revolutionary alternative to antibiotics to combat bacterial infectious diseases" is selected by CaixaImpulse Consolidate as one of the leading biomedical projects to make the leap to the market. RA01 is an innovative alternative treatment to antibiotics to combat infectious diseases caused by bacteria resistant to antibiotics. The project has been selected based on its ability to solve the challenges presented by the search for alternatives to antibiotics to combat infectious diseases. The research team has an established company that will start to include patients in its first clinical trial next year. This research will ...